Joseph D. Lutgring

2.0k total citations
50 papers, 1.2k citations indexed

About

Joseph D. Lutgring is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Joseph D. Lutgring has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Medicine, 21 papers in Clinical Biochemistry and 15 papers in Infectious Diseases. Recurrent topics in Joseph D. Lutgring's work include Antibiotic Resistance in Bacteria (23 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Antibiotic Use and Resistance (14 papers). Joseph D. Lutgring is often cited by papers focused on Antibiotic Resistance in Bacteria (23 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Antibiotic Use and Resistance (14 papers). Joseph D. Lutgring collaborates with scholars based in United States, Uganda and Australia. Joseph D. Lutgring's co-authors include Brandi Limbago, Michael E. Berend, Merrill A. Ritter, Kenneth Davis, Jeffery L. Pierson, R. Michael Meneghini, J. Kamile Rasheed, Allison C. Brown, David Lonsway and Karen Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Bone and Joint Surgery.

In The Last Decade

Joseph D. Lutgring

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph D. Lutgring United States	17	597	333	279	242	192	50	1.2k
Didier Tandé France	15	427 0.7×	224 0.7×	213 0.8×	230 1.0×	96 0.5×	27	893
Mesut Yılmaz Türkiye	18	531 0.9×	227 0.7×	84 0.3×	241 1.0×	174 0.9×	74	1.2k
Joshua T. Freeman New Zealand	18	377 0.6×	196 0.6×	108 0.4×	190 0.8×	62 0.3×	40	831
Angella Charnot‐Katsikas United States	15	428 0.7×	69 0.2×	327 1.2×	210 0.9×	114 0.6×	30	940
Parul Shah India	10	655 1.1×	103 0.3×	65 0.2×	261 1.1×	158 0.8×	38	945
Tsilia Lazarovitch Israel	18	321 0.5×	106 0.3×	157 0.6×	248 1.0×	115 0.6×	40	1.0k
D. Sofianou Greece	16	616 1.0×	70 0.2×	183 0.7×	270 1.1×	168 0.9×	39	1.1k
Fatima M’Zali France	17	792 1.3×	87 0.3×	86 0.3×	354 1.5×	118 0.6×	38	998
María Ángeles Orellana Spain	20	428 0.7×	74 0.2×	171 0.6×	251 1.0×	109 0.6×	60	1.0k
Rajeev Soman India	16	362 0.6×	122 0.4×	66 0.2×	163 0.7×	140 0.7×	82	797

Countries citing papers authored by Joseph D. Lutgring

Since Specialization

Citations

This map shows the geographic impact of Joseph D. Lutgring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D. Lutgring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D. Lutgring more than expected).

Fields of papers citing papers by Joseph D. Lutgring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph D. Lutgring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D. Lutgring. The network helps show where Joseph D. Lutgring may publish in the future.

Co-authorship network of co-authors of Joseph D. Lutgring

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph D. Lutgring. A scholar is included among the top collaborators of Joseph D. Lutgring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph D. Lutgring. Joseph D. Lutgring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolford, Hannah, Natalie McCarthy, James Baggs, et al.. (2025). Antimicrobial-Resistant Infections in Hospitalized Patients. JAMA Network Open. 8(3). e2462059–e2462059. 6 indexed citations

Lutgring, Joseph D., Kathryn A. Haass, Natalie McCarthy, et al.. (2025). The Impact of a Nationwide Blood Culture Bottle Shortage in 2024 on Healthcare Facilities in the United States. Clinical Infectious Diseases.

Kuti, Joseph L., Joseph D. Lutgring, Patricia J. Simner, Samia N. Naccache, & Emily L. Heil. (2025). Point-Counterpoint: Cascade reporting—useful tool to support antimicrobial stewardship, or dangerously misleading. Journal of Clinical Microbiology. 63(7). e0170824–e0170824.

Currie, Dustin W., Joseph D. Lutgring, Sophia V. Kazakova, et al.. (2025). Comparison of Medicare claims-based Clostridioides difficile infection epidemiologic case classification algorithms to medical record review by the Emerging Infections Program using a linked cohort, 2016–2021. Infection Control and Hospital Epidemiology. 46(5). 488–496.

Kent, Alyssa G., Davina Campbell, Mark Burroughs, et al.. (2024). Sentinel Surveillance reveals phylogenetic diversity and detection of linear plasmids harboring vanA and optrA among enterococci collected in the United States. Antimicrobial Agents and Chemotherapy. 68(11). e0059124–e0059124. 5 indexed citations

Orazi, Giulia, Ashley Paulick, Lori A. Rowe, et al.. (2024). Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016. Microbiology Resource Announcements. 13(7). e0112823–e0112823.

Hatfield, Kelly M, Sarah Kabbani, Dustin W. Currie, et al.. (2024). Utilization of multiplex molecular panels for urinary tract infections, Medicare claims, 2016 – 2022. SHILAP Revista de lepidopterología. 4(S1). s78–s78.

Patel, Jean B., Kevin Alby, Romney M. Humphries, et al.. (2023). Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022. Journal of Clinical Microbiology. 61(10). e0115422–e0115422. 10 indexed citations

Lutgring, Joseph D., Alyssa G. Kent, Jolene R. Bowers, et al.. (2023). Comparison of carbapenem-susceptible and carbapenem-resistant Enterobacterales at nine sites in the USA, 2013–2016: a resource for antimicrobial resistance investigators. Microbial Genomics. 9(11). 3 indexed citations

10.

Babiker, Ahmed, Chris Bower, Joseph D. Lutgring, et al.. (2022). Clinical and Genomic Epidemiology of mcr-9 -Carrying Carbapenem-Resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012 to 2017. Microbiology Spectrum. 10(4). e0252221–e0252221. 7 indexed citations

11.

Costantini, Verónica, Kenny Nguyen, Zoë L. Lyski, et al.. (2022). Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG. The Journal of Immunology. 208(6). 1500–1508. 15 indexed citations

12.

Campbell, Davina, Maria Karlsson, J. Kamile Rasheed, et al.. (2022). Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019. SHILAP Revista de lepidopterología. 2(S1). s52–s52. 1 indexed citations

13.

McKay, Susannah L., Valérie Albrecht, Valerie Stevens, et al.. (2022). Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013–2017. Microbial Drug Resistance. 28(6). 645–653. 21 indexed citations

14.

Sharma, Aditya, Prabasaj Paul, Joseph D. Lutgring, et al.. (2021). Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies. BMC Public Health. 21(1). 1412–1412. 14 indexed citations

15.

Vallabhaneni, Snigdha, J. Huang, Julian E. Grass, et al.. (2021). Antimicrobial Susceptibility Profiles To Predict the Presence of Carbapenemase Genes among Carbapenem-Resistant Pseudomonas aeruginosa Isolates. Journal of Clinical Microbiology. 59(6). 12 indexed citations

16.

Ransom, Eric M., Jean B. Patel, Joseph D. Lutgring, et al.. (2020). Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels. Journal of Clinical Microbiology. 58(4). 18 indexed citations

17.

Bower, Chris, Max W. Adelman, Jessica Howard‐Anderson, et al.. (2020). Carbapenem-Resistant Enterobacteriaceae Resistant Only to Ertapenem: An Epidemiologically Distinct Cohort, Atlanta, 2016–2018. Infection Control and Hospital Epidemiology. 41(S1). s463–s464. 1 indexed citations

18.

Ransom, Eric M., Karen Anderson, David Lonsway, et al.. (2020). Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales. Journal of Antimicrobial Chemotherapy. 76(4). 979–983. 19 indexed citations

19.

Campbell, Davina, Uzma Ansari, Joseph D. Lutgring, et al.. (2019). Development and Validation of a Clinical Laboratory Improvement Amendments-Compliant Multiplex Real-Time PCR Assay for Detection of mcr Genes. Microbial Drug Resistance. 25(7). 991–996. 15 indexed citations

20.

Ritter, Merrill A., Joseph D. Lutgring, Kenneth Davis, Michael E. Berend, & John B. Meding. (2006). A Clinical, Radiographic, and Cost Comparison of Cerclage Techniques: Wires vs Cables. The Journal of Arthroplasty. 21(7). 1064–1067. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact